David Orlikowski
Overview
Explore the profile of David Orlikowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazeraud A, Sivanandamoorthy S, Mancusi R, Clair B, Friedman D, Fadel F, et al.
Sci Rep
. 2024 Aug;
14(1):19523.
PMID: 39174610
Mechanical ventilation in myasthenic crisis is not standardized and is at high risk of failure. We investigated liberation from mechanical ventilation during myasthenic crisis using a prolonged spontaneous breathing trials...
2.
Retailleau E, Lefeuvre C, Antonio M, Bouhour F, Tard C, Salort-Campana E, et al.
Eur J Neurol
. 2024 Aug;
31(10):e16428.
PMID: 39109844
Background And Purpose: Late onset Pompe disease (LOPD) is a rare neuromuscular disorder caused by a deficit in acid alpha-glucosidase. Macroglossia and swallowing disorders have already been reported, but no...
3.
Schoser B, van der Beek N, Broomfield A, Brusse E, Diaz-Manera J, Hahn A, et al.
Eur J Neurol
. 2024 Jun;
31(9):e16383.
PMID: 38873957
Background And Purpose: Two novel enzyme replacement therapies (ERTs), studied in phase 3 trials in late-onset Pompe patients, reached marketing authorization by the European Medicines Agency in 2022 and 2023....
4.
Fayssoil A, Mansencal N, Nguyen L, Nardi O, Ben Yaou R, Leturcq F, et al.
J Am Heart Assoc
. 2023 Aug;
12(16):e027231.
PMID: 37581390
Background Chronic respiratory failure and heart involvement may occur in Duchenne muscular dystrophy. We aimed to assess the prognostic value of the right ventricular (RV) systolic dysfunction in patients with...
5.
Lessard L, Tard C, Salort-Campana E, Sacconi S, Behin A, Bassez G, et al.
Mol Genet Metab
. 2023 Jun;
139(3):107611.
PMID: 37285781
Background And Objectives: Pompe disease is a rare hereditary glycogen storage disorder due to lysosomal acid alpha-glucosidase deficiency. Enzyme replacement therapy (ERT) is the only available treatment. Infusion-associated reactions (IAR)...
6.
Thiveaud D, Orlikowski D, Olle F, Camus D, Josseran A, Degon P, et al.
Therapie
. 2022 Nov;
78(1):53-65.
PMID: 36435676
Information is generally a major pillar in the relationship of trust between the patient and their healthcare team. In the case of medical devices, which are operator-dependent and for which...
7.
Thiveaud D, Orlikowski D, Olle F, Camus D, Josseran A, Degon P, et al.
Therapie
. 2022 Nov;
78(1):39-52.
PMID: 36424211
No abstract available.
8.
Gault E, Orlikowski D, Gaillard J, Rozenberg F, Leruez-Ville M
Virologie (Montrouge)
. 2022 Sep;
15(5):319-325.
PMID: 36151690
Guillain-Barré syndrome (GBS) is the leading cause of acute flaccid paralysis in developed countries. It usually follows an infectious disease, cytomegalovirus (CMV) being one of the most frequently identified triggering...
9.
Bessis S, Dinh A, Gautier S, Davido B, Levy J, Lawrence C, et al.
Front Public Health
. 2022 Jun;
10:709848.
PMID: 35685762
The COVID-19 pandemic is a unique crisis challenging healthcare institutions as it rapidly overwhelmed hospitals due to a large influx of patients. This major event forced all the components of...
10.
Leotard A, Delorme M, Delord V, Niel-Duriez M, Orlikowski D, Annane D, et al.
Chron Respir Dis
. 2022 Mar;
18:14799731211036901.
PMID: 35289675
Purpose: Non-invasive ventilation (NIV) is the reference standard for managing chronic hypoventilation in patients with Duchenne muscular dystrophy (DMD). In these patients, upper airway obstruction under NIV may compromise efficacy...